BeStock  
Stocks › Biotechnology › REPL

Replimune REPL

US equityMarket cap rank #2747Biotechnology
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–

Earnings

QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q228 Oct 2026Pre Market±11.7%+23.07%Bigger than priced
2025/Q422 May 2025Pre Market±33.7%+3.55%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Sep 2026

Revenue$0.00
Operating profit-$56.04M+33.2% YoY
Net profit-$57.12M+31.3% YoY
Diluted EPS-$0.54+40.0% YoY
Free cash flow-$47.78M+42.1% YoY
Operating cash flow-$47.70M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-66.3MDec '24$-74.1MMar '25$-86.7MJun '25$-83.1MSep '25$-70.9MDec '25$-73.2MMar '26$-69.8MJun '26$-57.1MSep '26

Profitability & balance sheet

Return on equity-115.8%
Return on assets-71.0%
Return on invested capital-77.4%
Current ratio7.11
Liabilities / assets45.2%
Cash & investments$307.83M
Total debt$123.15M
Net cash (debt)$184.68M

Discussion

No comments yet — be the first to weigh in on REPL.

Sign in to join the discussion.

Scroll to Top